DEF: Exicure Schedules 2025 Annual Meeting, Board & Auditor Votes
Definitive Proxy Statement
Exicure, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on November 6, 2025, to vote on director elections, auditor ratification, and executive compensation.
Summary
- The 2025 Annual Meeting of Stockholders will be held virtually on Thursday, November 6, 2025, at 5:00 p.m. Central Time.
- Stockholders will vote on the election of two Class II directors, Aejin Hwang and Sangjin Yeo, to hold office until the 2028 Annual Meeting.
- The meeting includes a proposal to ratify the selection of CBIZ LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- An advisory vote on executive compensation for 2024 will also be conducted.
- The record date for stockholders entitled to vote at the Annual Meeting is September 9, 2025.
- The company became a controlled company under Nasdaq rules in December 2024 following increased equity interest by Exicure HiTron Inc.
- Net loss decreased from $(16,914) thousand in 2023 to $(9,701) thousand in 2024.
- Total Shareholder Return (TSR) increased to $53.27 in 2024 from $9.57 in 2023, based on an initial $100 investment on December 31, 2021.
Sentiment
Score: 6
Explanation: The company reported a reduced net loss and a significant increase in Total Shareholder Return for 2024, which are positive financial indicators. However, the company remains in a 'transitional state with limited operations,' has experienced substantial board turnover, and has several instances of late insider trading reports, indicating ongoing operational and compliance challenges. The company also became a controlled company, which impacts governance.
Positives
- Net loss decreased significantly from $(16,914) thousand in 2023 to $(9,701) thousand in 2024.
- Total Shareholder Return (TSR) increased substantially to $53.27 in 2024 from $9.57 in 2023, indicating a positive stock price performance.
- The Audit Committee's current members (Sangjin Yeo, Aejin Hwang, Dongho Lee) are all determined to be independent, and Mr. Yeo is an audit committee financial expert.
- The company has adopted a Code of Business Conduct and Ethics and an Insider Trading, Anti-Hedging and Anti-Pledging Policy to promote compliance and good governance.
Negatives
- The company is described as being in a 'transitional state with limited operations,' indicating ongoing operational uncertainty.
- There has been substantial turnover in the Board of Directors during 2023 and 2024, with multiple directors resigning.
- The Board of Directors currently does not have a chairperson or a lead independent director.
- Several Section 16(a) reports (insider trading reports) were filed late by HiTron, former officers, and SangSangIn Investment & Securities Co., Ltd., indicating compliance issues.
- The Compensation Committee and Nominating and Corporate Governance Committee currently consist of only one member (Dongho Lee), although the Board intends to add more independent members.
- The Board has not adopted a policy regarding the consideration of diversity in identifying director nominees.
Risks
- The company is in a 'transitional state with limited operations,' which may pose risks to future stability and growth.
- The absence of a Board chairperson or lead independent director could impact leadership and oversight effectiveness, especially during a transitional period.
- As a controlled company under Nasdaq rules, the company is exempt from certain independence requirements for its Board and committees, which could affect corporate governance standards.
- The company's future strategy and funding situation are still developing, implying potential financial and operational uncertainties.
Future Outlook
The Board of Directors expects to reconsider its leadership structure as the company's future strategy and funding situation develops. The company no longer qualifies as an emerging growth company under applicable SEC rules as of 2024.
Management Comments
- The Board of Directors expects to reconsider our leadership structure as our future strategy and funding situation develops.
Industry Context
This filing primarily focuses on corporate governance, executive compensation, and shareholder voting matters, rather than providing specific industry-wide trends or competitive analysis. The company's status as a 'controlled company' under Nasdaq rules indicates a significant ownership concentration, which is a key structural aspect.
Comparison to Industry Standards
- The company's transition to a 'controlled company' status under Nasdaq rules means it is exempt from certain independence requirements for its Board and committees, which deviates from best practices for corporate governance typically expected of non-controlled public companies.
- The significant turnover in the Board and executive management, coupled with the company being in a 'transitional state with limited operations,' suggests a period of instability that contrasts with established, stable industry players.
- The numerous late Section 16(a) filings by insiders indicate a lapse in compliance with regulatory reporting standards, which is generally not observed in well-governed, mature companies within the industry.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Paul Kang | Andy Yoo | 2024-12-20 | Appointment of new CEO, with Paul Kang transitioning duties until February 27, 2025. |
| Chief Financial Officer | Jiyoung Hwang | Seung Ik Baik | 2024-12-20 | Appointment of new CFO. |
| Chief Strategy Officer | NA | Jiyoung Hwang | 2024-12-20 | Appointed after resigning as CFO, then resigned from this role in January 2025. |
| Director | Hyuk Joon (Raymond) Ko | NA | 2024-12 | Resignation from the Board. |
| Director | Hojoon Lee | NA | 2024-11 | Resignation from the Board. |
| Director | Minhee Eom | NA | 2024-12 | Resignation from the Board. |
| Director | Eui Yull Hwang | NA | 2024-11-21 | Resignation from the Board. |
| Director | NA | Ho Jung John | 2024-12-17 | Appointment to the Board, later resigned. |
| Director | NA | Chang Keun Choi | 2024-12-17 | Appointment to the Board, later resigned. |
| Director | NA | Sangwook Song | 2024-12-17 | Appointment to the Board, later resigned. |
| Director | NA | Minwoo Kang | 2024-12-17 | Appointment to the Board, later resigned. |
| Director | Ho Jung John | NA | 2025-09-08 | Resignation from the Board. |
| Director | Chang Keun Choi | NA | 2025-09-08 | Resignation from the Board. |
| Director | Sangwook Song | NA | 2025-09-08 | Resignation from the Board. |
| Director | Minwoo Kang | NA | 2025-09-08 | Resignation from the Board. |
| Director | NA | Sangjin Yeo | 2025-09-08 | Appointment to the Board and Audit Committee Chairman. |
| Director | NA | Aejin Hwang | 2025-09-08 | Appointment to the Board and Audit Committee. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Structure | The Board of Directors is divided into three classes with three-year terms. The company became a controlled company under Nasdaq rules in December 2024, exempting it from requirements for a majority independent board and independent compensation/nominating committees. | 2024-12 | Reduces the requirement for independent directors and committees, potentially concentrating control with the majority shareholder, HiTron. |
| Board Leadership | The Board currently does not have a chairperson or a lead independent director, with management members acting in the role of chairperson at meetings. | Ongoing | May lead to less independent oversight and potentially less effective governance, though the Board expects to reconsider this structure. |
| Committee Composition | The Audit Committee is comprised of Sangjin Yeo (Chairperson), Aejin Hwang, and Dongho Lee, all determined independent. The Compensation Committee and Nominating and Corporate Governance Committee currently consist of only Dongho Lee, with plans to add more independent members. | 2025-09-08 (Audit Committee appointments) | The Audit Committee's independence is positive, but the limited membership of other key committees, even with controlled company exemptions, could raise concerns about robust oversight. |
| Policies and Procedures | Adopted a written related person transaction policy, a Code of Business Conduct and Ethics, and an Insider Trading, Anti-Hedging and Anti-Pledging Policy. | Various, ongoing | Enhances internal controls and compliance framework, promoting ethical conduct and transparency in related party dealings and securities trading. |
| Director Diversity Policy | The Board has not adopted a policy regarding the consideration of diversity in identifying director nominees. | Ongoing | May limit the range of perspectives and experiences on the Board, potentially hindering decision-making and alignment with broader stakeholder expectations for diversity. |
Related Party Transactions
- Common Stock Purchase Agreement with HiTron Systems Inc. (November 6, 2024) for 433,333 shares at $3.00/share.
- Subsequent Common Stock Purchase Agreement with HiTron (November 13, 2024) for 2,900,000 additional shares at $3.00/share, granting HiTron rights to nominate Board members.
- Common Stock Purchase Agreement with SangSangIn Investment & Securities Co., Ltd. (December 9, 2024) for 433,332 shares at $4.61/share.
- Securities Purchase Agreement with CBI USA, Inc. (September 26, 2022) for a private placement of 680,000 shares at $8.00/share, which closed on February 24, 2023. DGP Co., Ltd. (an affiliate of CBI USA) acquired these shares and later sold portions to third parties.
- Consulting Agreement with Alta (an entity controlled by former CEO Paul Kang) effective February 27, 2025, for an initial fee of $99,000 and a monthly fee of $12,500.
Stakeholder Impact
- Shareholders: Will participate in the annual meeting to vote on key governance matters, including director elections, auditor ratification, and executive compensation. The significant ownership by HiTron (52.8%) and other institutional investors (DGP, SangSangIn) indicates concentrated voting power.
- Employees: The company sponsors a 401(k) plan with matching contributions. Executive compensation adjustments and severance packages for management are detailed.
- Management: Significant changes in CEO and CFO roles, with substantial salary adjustments and severance packages for current executives, indicating a restructuring of leadership.
- Auditor: CBIZ LLP's selection for fiscal year 2025 is subject to shareholder ratification, impacting their ongoing engagement with the company.
- Regulatory Bodies: The numerous late Section 16(a) filings highlight compliance issues that may draw regulatory scrutiny.
Next Steps
- Hold the 2025 Annual Meeting of Stockholders virtually on November 6, 2025.
- Elect two Class II directors (Aejin Hwang and Sangjin Yeo) to serve until the 2028 Annual Meeting.
- Ratify CBIZ LLP as the independent registered public accounting firm for fiscal year 2025.
- Conduct an advisory vote on executive compensation for 2024.
- The Board of Directors expects to reconsider its leadership structure as the company's future strategy and funding develops.
- The Compensation Committee and Nominating and Corporate Governance Committee will add more independent members.
- File a Form 8-K with final voting results within four business days following the Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| 2022-09-26 | Company entered into a securities purchase agreement with CBI USA, Inc. |
| 2023-02-24 | Private Placement with CBI USA, Inc. closed. |
| 2023-06-23 | DGP exercised option to acquire 680,000 shares of Common Stock from CBI USA. |
| 2023-08-21 | Paul Kang appointed Chief Executive Officer; Dongho Lee and Hojoon Lee appointed to the Board of Directors. |
| 2023-08-28 | Jiyoung Hwang appointed Chief Financial Officer. |
| 2023-09-26 | Minhee Eom appointed to the Board of Directors. |
| 2024-01-01 | 2017 Equity Incentive Plan automatically increased by 153,333 shares. |
| 2024-02-16 | Joshua Miller transaction (reported late on March 6, 2024). |
| 2024-02 | DGP sold 10% (68,000 shares) of its shares to a third party. |
| 2024-05-16 | Joshua Miller transaction (reported late on May 23, 2024). |
| 2024-08-16 | Joshua Miller transaction (reported late on August 21, 2024). |
| 2024-09-26 | Eui Yull Hwang appointed to the Board of Directors. |
| 2024-11-06 | Company entered into a common stock purchase agreement with HiTron Systems Inc. |
| 2024-11-12 | Common stock purchase agreement with HiTron Systems Inc. executed. |
| 2024-11-13 | Subsequent Common Stock Purchase Agreement with HiTron for 2,900,000 additional shares. |
| 2024-11-16 | Joshua Miller transaction (reported late on November 26, 2024). |
| 2024-11-21 | Eui Yull Hwang resigned from the Board. |
| 2024-11 | Hojoon Lee resigned from the Board. |
| 2024-12-09 | Company entered into a Common Stock Purchase Agreement with SangSangIn Investment & Securities Co., Ltd. |
| 2024-12-12 | SangSangIn Investment & Securities Co., Ltd. became an insider (reported late on December 23, 2024). |
| 2024-12-17 | Ho Jung John, Chang Keun Choi, Sangwook Song, and Minwoo Kang appointed to the Board of Directors. |
| 2024-12-19 | Hojung John Song, Chang Keun Choi, Sangwook Song, Minwoo Kang appointed as former officers (reported late on March 24, 2025). |
| 2024-12-20 | Andy Yoo appointed Chief Executive Officer; Seung Ik Baik appointed Chief Financial Officer; Jiyoung Hwang resigned as CFO and appointed Chief Strategy Officer. |
| 2024-12-26 | HiTron transaction (reported late on March 26, 2025). |
| 2024-12 | Hyuk Joon (Raymond) Ko and Minhee Eom resigned from the Board. |
| 2025-01 | Jiyoung Hwang resigned as Chief Strategy Officer. |
| 2025-02-24 | DGP sold 424,611 shares to another third party. |
| 2025-02-27 | Paul Kang resigned as Chief Executive Officer; Consulting Agreement with Alta (Mr. Kang's entity) became effective. |
| 2025-03-18 | Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC. |
| 2025-04-01 | Effective date for adjusted annual base salaries for Andy Yoo ($480,000) and Seung Ik Baik ($300,000). |
| 2025-06-06 | Board approved severance packages and adjusted salaries for Andy Yoo and Seung Ik Baik. |
| 2025-09-08 | Ho Jung John, Chang Keun Choi, Sangwook Song, and Minwoo Kang resigned from the Board; Sangjin Yeo and Aejin Hwang appointed to the Board and Audit Committee. |
| 2025-09-09 | Record date for the 2025 Annual Meeting of Stockholders. |
| 2025-09-23 | Proxy materials first distributed or sent to stockholders. |
| 2025-11-05 | Deadline for Internet or telephone proxy votes (11:59 p.m. Eastern Time). |
| 2025-11-06 | 2025 Annual Meeting of Stockholders to be held; Term expiration for Class II directors. |
| 2026 | Term expiration for Class III director Seung Ik Baik. |
| 2026-05-26 | Deadline for stockholder proposals for 2026 proxy statement (Rule 14a-8). |
| 2026-07-09 | Earliest date for advance notice of stockholder proposals for 2026 Annual Meeting (not for proxy statement inclusion). |
| 2026-08-08 | Latest date for advance notice of stockholder proposals for 2026 Annual Meeting (not for proxy statement inclusion). |
| 2026-09-07 | Deadline for notice under universal proxy rules (Rule 14a-19) for director nominees. |
| 2027 | Term expiration for Class I directors Andy Yoo and Dongho Lee. |
| 2028 | Proposed term expiration for elected Class II directors. |
Recommendation
holdWhile the company showed improvement in reducing its net loss and experienced a significant increase in Total Shareholder Return in 2024, it remains in a 'transitional state with limited operations.' The recent substantial changes in management, board composition, and the company becoming a 'controlled company' under Nasdaq rules introduce both potential for strategic shifts and governance uncertainties. The numerous late Section 16(a) filings also point to compliance issues. Given these mixed signals, a 'hold' recommendation is appropriate as investors should monitor the execution of the new management team's strategy and the company's operational stability before making further investment decisions.
Keywords
Exicure, XCUR, SEC filing, proxy statement, annual meeting, corporate governance, director election, auditor ratification, executive compensation, shareholder vote, controlled company, HiTron, financial results, net loss, TSR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.